Gurugram-based dialysis care provider VitusCare has raised $3 million (nearly Rs 30 crore) in a Series B round, with participation from Singapore-based healthcare growth equity firm Liberty Ridge Capital, HDFC Bank, Equentis and NAFA Capital Advisors.
Existing investors 1Crowd and 3i Partners also took part, along with several angel investors, the startup said.
VitusCare will use the funding to expand its network of dialysis centres, build technology, train staff and expand outside India.
The Series B comes about two and a half years after VitusCare raised $2.7 million in a Series A round led by Tomorrow Capital in April 2024, with 1Crowd, 3i Partners and a group of angel investors joining. At that point, the company said it had raised about $5 million across all its rounds, including a seed round of Rs 10.83 crore in 2019.
The new round takes its total funding to roughly $8 million.
How much has VitusCare grown?
The startup said it has nearly tripled its revenue since its previous funding round in 2024. Over the same period, its network grew from 22 to more than 60 dialysis centres across nine states and over 50 cities, and its workforce rose from 110 to 300 employees.
VitusCare said it has treated more than 35,000 patients and carried out over 8 lakh dialysis sessions so far. It reported positive corporate EBITDA in FY26, which it attributed to newly opened centres breaking even faster and same-centre growth of over 30%.
“This fundraise marks an important milestone in VitusCare’s journey. We are focused on building a sustainable dialysis care model that combines clinical excellence with operational efficiency,” said Prabhat Shrivastava, founder and CEO of VitusCare.
“The confidence our investors have shown in us reinforces our approach to disciplined growth, improving centre-level performance and strengthening our operational foundation,” he added.
Vasavi Vittal, founder and MD of Liberty Ridge Capital, said VitusCare’s capital-light model “offers a differentiated approach to delivering specialised dialysis care through existing hospital infrastructure.”
“We see an opportunity for VitusCare to build on this foundation and expand its presence across India and select international markets,” Vittal said.
The shop-in-shop model
VitusCare does not build standalone dialysis clinics. It runs what it calls a capital-light “shop-in-shop” model, setting up dialysis units inside existing hospitals.
It brings the dialysis machines, trained technicians, technology and day-to-day operations, while the partner hospital provides the space and infrastructure. This lets a provider expand its reach with lower capital spending, particularly in Tier II and Tier III cities.
Founded in 2017 by Prabhat Shrivastava, Saurabh Pokhariyal and Pankaj Tandon, VitusCare provides dialysis services. Pokhariyal, a nephrologist, served as the company’s chief medical director, while Tandon held the position of chief financial officer (CFO), according to VitusCare’s announcement of its previous funding round.
VitusCare aims to grow to more than 100 centres by the end of FY27, which would mean adding about 40 centres in a little over four months. It is also exploring select markets in Asia.
The startup is building what it calls AI-native business modules to improve how care is delivered, and plans to set up a Technician Academy to train dialysis professionals.
India faces substantial demand for dialysis, with an estimated 2.2 lakh new patients developing end-stage renal disease every year, according to government figures.
The government also supports dialysis services under the Pradhan Mantri National Dialysis Programme, launched in 2016 to provide free treatment to patients below the poverty line. As of 30 June 2025, the programme had 1,704 operational centres across 751 districts, Minister of State for Health Prataprao Jadhav said in a written reply in the Lok Sabha.
Separately, news agency IANS reported that approximately 28.50 lakh patients had availed themselves of dialysis services under the programme.
VitusCare competes with private players such as NephroPlus, Apex Kidney Care, DCDC Kidney Care, 7Med and Rahi Care.


/indianstartupnews/media/media_files/2026/06/17/desktop-728-x-90-1-2026-06-17-17-20-35.png)

